文献速递主动脉外科瓣膜外科

保留主动脉瓣的主动脉根部置换联合二尖瓣修复的临床结果

Clinical results of combined aortic valve-sparing root replacement and mitral valve repair.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

院内无死亡,10年总生存率90%,10年免于再手术率84%;结缔组织病组10年免于再手术率显著低于非结缔组织病组(63% vs 91%,log rank P=0.031)。

要点

  • 联合保留主动脉瓣的根部置换与二尖瓣修复可安全实施,长期生存良好。
  • 结缔组织病组10年免于再手术率显著低于非结缔组织病组。
  • 经主动脉缘对缘修复的大多数患者需再次二尖瓣手术。

核心结论

  • 联合保留主动脉瓣的根部置换与二尖瓣手术复杂但可安全实施,长期生存与修复耐久性良好。
  • 结缔组织病患者需重视二尖瓣修复技术,标准Carpentier技术至关重要。

研究设计与样本

  • 按是否合并结缔组织病分为两组:结缔组织病组13例,非结缔组织病组32例。
  • 采用Kaplan-Meier法计算实际生存率与免于再手术率,log rank检验进行统计评估。

主要发现

  • 院内无死亡,3例(7%)需植入起搏器。
  • 10年总生存率为90%(95%CI:64-97%)。
  • 10年免于所有再手术率为84%(95%CI:64-93%)。
  • 两组10年生存率无统计学显著差异(log rank P=0.146)。
  • 结缔组织病组10年免于再手术率显著低于非结缔组织病组(63% vs 91%,log rank P=0.031)。

临床怎么用

  • 对主动脉根部病变合并二尖瓣反流患者可考虑双瓣保留策略,但需认识其复杂性。
  • 结缔组织病患者行二尖瓣修复时应严格应用标准Carpentier技术以改善修复耐久性。
  • 经主动脉缘对缘修复二尖瓣后需密切随访再手术风险。

局限性

  • 结缔组织病组仅13例,亚组比较统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aortic valve-sparing root replacement using the reimplantation technique and mitral valve (MV) repair are well-established surgical approaches for the treatment of aortic root pathologies and mitral valve insufficiency. However, the management of concomitant diseases with a dual valve-preserving strategy remains poorly described. Therefore, the aim of this study is to evaluate the long-term outcomes of concomitant valve-sparing surgery and MV repair. METHODS: This case series includes all the patients who underwent combined valve-sparing root replacement and MV repair at Cliniques Universitaires Saint-Luc (Brussels, Belgium) between January 2000 and June 2022. Actual survival rate and freedom from reoperation were calculated by the Kaplan-Meier method, and the log rank test was used for statistical evaluation. RESULTS: Forty-five patients were included in the study; they were divided into two groups (13 patients with and 32 patients without connective tissue disorders). There was no hospital mortality. Three patients (7%) required pacemaker implantation. Overall survival at 10 years was 90% (95% confidence interval [CI]: 64-97%). Furthermore, freedom from all reoperations at 10 years was 84% (95% CI: 64-93%). Analysing the two subgroups, we found no statistically significant difference in terms of 10-year survival (log rank P = 0.146). However, freedom from reoperation at 10 years was significantly lower in the connective tissue disorder group (63% vs 91%, log rank P = 0.031). Most patients treated with transaortic edge-to-edge repair required MV reoperation. CONCLUSIONS: Combined valve-sparing root replacement with the reimplantation technique and MV operations are complex surgeries. However, they can be performed safely, with excellent long-term survival and repair durability. Applying standard Carpentier techniques for MV repair is crucial, especially in patients with connective tissue disorders.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lorenz V, Jahanyar J, Mastrobuoni S, et al. Clinical results of combined aortic valve-sparing root replacement and mitral valve repair. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40080707. doi:10.1093/icvts/ivaf067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。